from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1393c/-

LFCtreatmentdescriptionclass of inhibitor

-0.377

Amikacinug/mL Amikacintranslation

-0.060

Cap5-10ug/mL Capreomycintranslation

-0.285

Rox10-50 ug/mL Roxithromycintranslation

-0.648

SM2-5 ug/mL Streptomycintranslation

-1.575

Tet5-10 ug/mL Tetracyclinetranslation

-0.127

Rif0.2-5ug/mL Rifampicintranscription

-0.023

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.090

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.427

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.562

CPZ10-50 ug/mL Chlorpromazinerespiration

0.623

Clofazimine10-13 ug/mL Clofaziminerespiration

0.476

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.314

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.105

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.158

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.873

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.126

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.134

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.025

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.352

KCN5-20 ug/mL Potassium cyaniderespiration

-0.967

NaN30.2-2 mM Sodium aziderespiration

0.542

Nigericin50 uM Nigericinrespiration

2.523

TRC10-150 ug/mL Triclosanrespiration

1.067

TRZ10-25 ug/mL Thioridazinerespiration

1.940

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.307

menadione6-10 ug/mL Menadionerespiration

0.020

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.188

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.294

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.204

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.115

NRP_1Non-replicating persistence stage 1dosRassociated

-0.547

Amp0.2mg/mL AmpicillincellWall

-0.466

Cephalexin20-100 ug/mL CephalexincellWall

-0.033

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.013

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.534

EMB10-20 ug/mL EthambutolcellWall

-0.017

Eta12-40 ug/mL EthionamidecellWall

-0.551

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.291

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.441

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.071

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.710

BZA0.12 mg/mL BenzamidearomaticAmides

-0.556

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.391

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.434

H2O24 mM hydrogen peroxideDNAdamaging

-0.361

Levo10 ug/mL LevofloxacinDNAdamaging

-0.384

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.529

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.406

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.023

UVUV-irradiationDNAdamaging

-0.522

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.350

Antimycin12.5-50 ug/mL Antimycin A?

0.046

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.657

PA_110-50 ug/mL Antitubercular compound PA-1?

0.113

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.608

PA8240.2-2 ug/mL PA-824?

-0.741

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.529

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.605

Verapamil50 uM Verapamil?

0.071

mercaptoethanol2 mM 2-Mercaptoethanol?

0.309

methoxatin10-20 ug/mL Methoxatin?